Evelo Biosciences Appoints Iain McInnes, M.B.Ch.B, Ph.D, to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
New study finds eight health conditions that mean Covid jabs could be less effective chroniclelive.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chroniclelive.co.uk Daily Mail and Mail on Sunday newspapers.
Looking in detail at patient vaccine response within disease subgroups, researchers found that a significant proportion of patients studied as part of the OCTAVE trial generate lower levels of SARS-CoV-2 antibody reactivity, when compared with healthy subjects after two SARS-CoV-2 vaccines.
The study, OCTAVE DUO, will offer people who are immunosuppressed or immunocompromised a Pfizer, Moderna or Novavax vaccine to determine whether this will give a stronger immune response than two doses.The £2.2 million study will build on the OCTAVE
Two doses of Covid vaccine are known to elicit high antibody response, but among some people with weak immune systems the response remains low or absent, according to a study. Researchers from the University of Birmingham in the UK said the group includes people with vasculitis disease inflammation of the blood vessels who are taking a strong medicine called rituximab, the BBC reported. 🍏 COVID-19 Vaccine Response Low for Some People with Weak Immune System: Study.